Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
boston blog main
boston top stories
inclisiran
6
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
regeneron pharmaceuticals
biotech
cholesterol
clinical trials
pcsk9
praluent
repatha
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
the medicines co.
wisconsin blog main
wisconsin top stories
alirocumab
alnylam pharmaceuticals
What
cholesterol
drug
lowering
medco
medicines
fda
new
roundup
twice
wave
abbvie’s
according
aces
acquire
agreed
akcea
announced
barbecuing
big
billion
bio
biotech
bringing
brings
camping
cardiologist
cases
cash
center
centers
ceo
check
cigarettes
clears
closer
company
compound
conference
control
day
Language
unset
6
×
Current search:
inclisiran
×
amgen
×
unset
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)